Date when the business acquisition agreement was executed, in YYYY-MM-DD format.

No definition available.

Name:	us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Name of the acquired entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463

+ Details

Name:	us-gaap_BusinessAcquisitionNameOfAcquiredEntity
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of voting equity interests acquired at the acquisition date in the business combination.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463

+ Details

Name:	us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477

+ Details

Name:	us-gaap_BusinessCombinationConsiderationTransferred1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (g)(2)
-URI https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463

+ Details

Name:	us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 25
-Paragraph 16
-URI https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460

+ Details

Name:	us-gaap_GoodwillPurchaseAccountingAdjustments
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585

+ Details

Name:	us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Additional Equity Interest Received Fair value.

+ References

No definition available.

+ Details

Name:	vff_AdditionalEquityInterestReceivedFairValue
Namespace Prefix:	vff_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Additional equity transferred percent.

+ References

No definition available.

+ Details

Name:	vff_AdditionalEquityTransferredPercent
Namespace Prefix:	vff_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Business combination notes payable.

+ References

No definition available.

+ Details

Name:	vff_BusinessCombinationNotesPayable
Namespace Prefix:	vff_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Equity earnings from unconsolidated entities.

+ References

No definition available.

+ Details

Name:	vff_IncomeLossFromEquityMethodInvestmentsNetOfTax
Namespace Prefix:	vff_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Number of Shares acquired.

+ References

No definition available.

+ Details

Name:	vff_NumberOfSharesAcquired
Namespace Prefix:	vff_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	srt_ConsolidatedEntitiesAxis=vff_PureSunfarmsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CurrencyAxis=currency_CAD
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=vff_EmeraldHealthMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_OwnershipAxis=vff_JointVentureMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Business Combinations - Pure Sunfarms Acquisition (Additional Information) (Details) $ in Thousands, $ in Thousands			3 Months Ended	9 Months Ended	12 Months Ended
	Nov. 02, 2020 CAD ($) shares	Nov. 02, 2020 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2020 USD ($)	Dec. 31, 2022 USD ($)	Nov. 02, 2020 USD ($) shares	Mar. 02, 2020 CAD ($)	Mar. 02, 2020 USD ($)
Business Acquisition [Line Items]
Goodwill					$ 3,755
Pure Sunfarms [Member]
Business Acquisition [Line Items]
Promissory notes payable						$ 15,011
Goodwill		$ 22,596
Gain on revaluation of previously held investment		$ 23,600
Additional equity transferred percent							2.50%	2.50%
Additional equity interest received fair value								$ 4,700
Pure Sunfarms [Member] \| Canada, Dollars [Member]
Business Acquisition [Line Items]
Goodwill	$ 30,618
Additional equity interest received fair value							$ 6,500
Emerald Health [Member] \| Pure Sunfarms [Member]
Business Acquisition [Line Items]
Business acquisition, date of acquisition agreement	Nov. 02, 2020	Nov. 02, 2020
Business acquisition, name of acquired entity	Emerald Health Therapeutics Inc. (“Emerald”)	Emerald Health Therapeutics Inc. (“Emerald”)
Business acquisition, percentage of voting interests acquired	100.00%					100.00%
Business combination, consideration transferred, total		$ 60,000
Payments to acquire businesses		$ 45,000
Promissory notes payable						$ 15,000
Emerald Health [Member] \| Pure Sunfarms [Member] \| Joint Venture [Member]
Business Acquisition [Line Items]
Business acquisition, percentage of voting interests acquired	58.70%					58.70%
Equity (losses) earnings from unconsolidated entities			$ 1,443	$ 5,437
Emerald Health [Member] \| Pure Sunfarms [Member] \| Canada, Dollars [Member]
Business Acquisition [Line Items]
Business combination, consideration transferred, total	$ 79,900
Payments to acquire businesses	60,000
Promissory notes payable	$ 19,900
Emerald Health [Member] \| Pure Sunfarms [Member] \| Common Stock [Member]
Business Acquisition [Line Items]
Number of shares acquired \| shares	36,958,500					36,958,500